Why the study?
Does the Liaison cardiac troponin I assay accurately detect myocardial injury and predict clinical outcomes in patients with unstable coronary artery disease?
Population
Patients with unstable coronary artery disease from the FRISC-II study, and a reference population.
Comparison
Liaison cardiac troponin I (cTnI) assay vs First-generation AxSYM assay, second-generation…
Design
Cohort
Authors
Loading...
May aid risk stratification in unstable CAD; leaves open prospective validation of this assay-specific threshold.
Does the Liaison cardiac troponin I assay accurately detect myocardial injury and predict clinical outcomes in patients with unstable coronary artery disease?
The Liaison cTnI assay is a sensitive biomarker test that identifies age-related differences in reference limits and predicts adverse clinical outcomes in patients with unstable coronary artery disease.
Venge et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: